Healthcare ❯ Pharmaceuticals ❯ Clinical Trials ❯ Cardiovascular Drugs
Sponsors say widespread use of TTR stabilizers likely obscured benefit and will reanalyse the full dataset for presentation at the ESC Congress in August.